Colleen R Kelly Selected Research

Clostridium Infections

3/2024	AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
7/2023	Efficacy, Safety, and Cost-effectiveness of Bezlotoxumab in Preventing Recurrent Clostridioides difficile Infection : Systematic Review and Meta-analysis.
7/2023	Redefining Clostridioides difficile infection antibiotic response and clinical outcomes.
1/2023	Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
11/2022	FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
1/2022	Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.
1/2022	Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.
1/2021	Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection.
11/2020	Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
1/2020	Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colleen R Kelly Research Topics

Disease

31	Clostridium Infections 03/2024 - 02/2012
9	Infections 03/2024 - 10/2015
8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024 - 08/2013
5	Ulcerative Colitis 07/2019 - 08/2013
3	Diarrhea 11/2016 - 08/2013
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2024
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2024
1	Pouchitis 03/2024
1	Alopecia (Baldness) 01/2017
1	Dysbiosis 01/2016
1	Weight Gain 01/2015
1	Reinfection 08/2013
1	Adenoma (Adenomas) 02/2003
1	Neoplasm Metastasis (Metastasis) 02/2003
1	Neoplasms (Cancer) 02/2003
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2003
1	Colorectal Neoplasms (Colorectal Cancer) 02/2003

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 02/2014
2	bezlotoxumabIBA 03/2024 - 07/2023
2	acceleratory factor from growth hormone (AcG)IBA 01/2022 - 01/2021
2	Metronidazole (Metric)FDA LinkGeneric 01/2018 - 08/2013
2	Vancomycin FDA LinkGeneric 08/2013 - 02/2012
1	EnzymesIBA 01/2023
1	Capsules (Microcapsules)IBA 01/2023
1	Bile Acids and Salts (Bile Acids)IBA 12/2016
1	Investigational DrugsIBA 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2003
1	rofecoxib (Vioxx)FDA Link 02/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2003
1	Antineoplastic Agents (Antineoplastics)IBA 02/2003
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2003
1	ProstaglandinsIBA 02/2003
1	Proteins (Proteins, Gene)FDA Link 02/2003
1	Interleukin-10 (Interleukin 10)IBA 02/2003
1	Interleukin-12 (IL 12)IBA 02/2003
1	Cyclin D1IBA 02/2003
1	beta CateninIBA 02/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2003

Therapy/Procedure

28	Fecal Microbiota Transplantation 03/2024 - 02/2012
11	Therapeutics 03/2024 - 02/2014
5	Transplantation 01/2020 - 07/2019
1	Enema (Enemas) 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Donor Selection 07/2019
1	Length of Stay 10/2015
1	Colectomy 07/2014